A citation-based method for searching scientific literature

Pi-Xiao Wang, Xiao-Jing Zhang, Pengcheng Luo, Xi Jiang, Peng Zhang, Junhong Guo, Guang-Nian Zhao, Xueyong Zhu, Yan Zhang, Sijun Yang, Hongliang Li. Nat Commun 2016
Times Cited: 95







List of co-cited articles
1031 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Targeting hepatic TRAF1-ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosis.
Mei Xiang, Pi-Xiao Wang, Ai-Bing Wang, Xiao-Jing Zhang, Yaxing Zhang, Peng Zhang, Fang-Hua Mei, Man-Hua Chen, Hongliang Li. J Hepatol 2016
99
28

The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling.
Yan-Xiao Ji, Peng Zhang, Xiao-Jing Zhang, Yi-Chao Zhao, Ke-Qiong Deng, Xi Jiang, Pi-Xiao Wang, Zan Huang, Hongliang Li. Nat Commun 2016
120
27

Interferon regulatory factor 3 constrains IKKβ/NF-κB signaling to alleviate hepatic steatosis and insulin resistance.
Xin-An Wang, Ran Zhang, Zhi-Gang She, Xiao-Fei Zhang, Ding-Sheng Jiang, Tao Wang, Lu Gao, Wei Deng, Shu-Min Zhang, Li-Hua Zhu,[...]. Hepatology 2014
108
26

Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates.
Pi-Xiao Wang, Yan-Xiao Ji, Xiao-Jing Zhang, Ling-Ping Zhao, Zhen-Zhen Yan, Peng Zhang, Li-Jun Shen, Xia Yang, Jing Fang, Song Tian,[...]. Nat Med 2017
145
26

Tmbim1 is a multivesicular body regulator that protects against non-alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4.
Guang-Nian Zhao, Peng Zhang, Jun Gong, Xiao-Jing Zhang, Pi-Xiao Wang, Miao Yin, Zhou Jiang, Li-Jun Shen, Yan-Xiao Ji, Jingjing Tong,[...]. Nat Med 2017
93
26

Tumor necrosis factor receptor-associated factor 5 (Traf5) acts as an essential negative regulator of hepatic steatosis.
Ling Gao, Pi-Xiao Wang, Yaxing Zhang, Chang-Jiang Yu, Yanxiao Ji, Xiaozhan Wang, Peng Zhang, Xi Jiang, Hong Jin, Zan Huang,[...]. J Hepatol 2016
36
66

The E3 ligase tripartite motif 8 targets TAK1 to promote insulin resistance and steatohepatitis.
Feng-Juan Yan, Xiao-Jing Zhang, Wen-Xin Wang, Yan-Xiao Ji, Pi-Xiao Wang, Yang Yang, Jun Gong, Li-Jun Shen, Xue-Yong Zhu, Zan Huang,[...]. Hepatology 2017
53
41

The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis.
Yan-Xiao Ji, Zan Huang, Xia Yang, Xiaozhan Wang, Ling-Ping Zhao, Pi-Xiao Wang, Xiao-Jing Zhang, Michele Alves-Bezerra, Lin Cai, Peng Zhang,[...]. Nat Med 2018
82
24

The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis.
Peng Zhang, Pi-Xiao Wang, Ling-Ping Zhao, Xin Zhang, Yan-Xiao Ji, Xiao-Jing Zhang, Chun Fang, Yue-Xin Lu, Xia Yang, Mao-Mao Gao,[...]. Nat Med 2018
121
20

Targeting TRAF3 signaling protects against hepatic ischemia/reperfusions injury.
Junfei Hu, Xue-Hai Zhu, Xiao-Jing Zhang, Pi-Xiao Wang, Ran Zhang, Peng Zhang, Guang-Nian Zhao, Lu Gao, Xiao-Fei Zhang, Song Tian,[...]. J Hepatol 2016
70
25

DKK3 expression in hepatocytes defines susceptibility to liver steatosis and obesity.
Lanfeng Xie, Pi-Xiao Wang, Peng Zhang, Xiao-Jing Zhang, Guang-Nian Zhao, Aibing Wang, Junhong Guo, Xueyong Zhu, Qin Zhang, Hongliang Li. J Hepatol 2016
48
35

TAK1-mediated autophagy and fatty acid oxidation prevent hepatosteatosis and tumorigenesis.
Sayaka Inokuchi-Shimizu, Eek Joong Park, Yoon Seok Roh, Ling Yang, Bi Zhang, Jingyi Song, Shuang Liang, Michael Pimienta, Koji Taniguchi, Xuefeng Wu,[...]. J Clin Invest 2014
120
16

Interferon regulatory factor 9 protects against hepatic insulin resistance and steatosis in male mice.
Xin-An Wang, Ran Zhang, Dingsheng Jiang, Wei Deng, Shumin Zhang, Shan Deng, Jinfeng Zhong, Tao Wang, Li-Hua Zhu, Li Yang,[...]. Hepatology 2013
64
25

Insulin resistance, inflammation, and non-alcoholic fatty liver disease.
Herbert Tilg, Alexander R Moschen. Trends Endocrinol Metab 2008
340
14

Design and validation of a histological scoring system for nonalcoholic fatty liver disease.
David E Kleiner, Elizabeth M Brunt, Mark Van Natta, Cynthia Behling, Melissa J Contos, Oscar W Cummings, Linda D Ferrell, Yao-Chang Liu, Michael S Torbenson, Aynur Unalp-Arida,[...]. Hepatology 2005
13

USP18 protects against hepatic steatosis and insulin resistance through its deubiquitinating activity.
Shimin An, Ling-Ping Zhao, Li-Jun Shen, Siyuan Wang, Kuo Zhang, Yu Qi, Jilin Zheng, Xiao-Jing Zhang, Xue-Yong Zhu, Rong Bao,[...]. Hepatology 2017
32
40

Progress and challenges in the prevention and control of nonalcoholic fatty liver disease.
Jingjing Cai, Xiao-Jing Zhang, Hongliang Li. Med Res Rev 2019
69
18

Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy.
Ke-Qiong Deng, Aibing Wang, Yan-Xiao Ji, Xiao-Jing Zhang, Jing Fang, Yan Zhang, Peng Zhang, Xi Jiang, Lu Gao, Xue-Yong Zhu,[...]. Nat Commun 2016
54
22

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.
Naga Chalasani, Zobair Younossi, Joel E Lavine, Michael Charlton, Kenneth Cusi, Mary Rinella, Stephen A Harrison, Elizabeth M Brunt, Arun J Sanyal. Hepatology 2018
12

Interferon regulatory factor 7 deficiency prevents diet-induced obesity and insulin resistance.
Xin-An Wang, Ran Zhang, Shumin Zhang, Shan Deng, Dingsheng Jiang, Jinfeng Zhong, Li Yang, Tao Wang, Shufen Hong, Sen Guo,[...]. Am J Physiol Endocrinol Metab 2013
69
15

Interferon regulatory factor signalings in cardiometabolic diseases.
Xiao-Jing Zhang, Peng Zhang, Hongliang Li. Hypertension 2015
41
26

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.
Zobair M Younossi, Aaron B Koenig, Dinan Abdelatif, Yousef Fazel, Linda Henry, Mark Wymer. Hepatology 2016
11

Reprogramming Innate Immune Signaling in Cardiometabolic Disease.
Yaxing Zhang, Xiao-Jing Zhang, Pi-Xiao Wang, Peng Zhang, Hongliang Li. Hypertension 2017
19
57

Inflammation and metabolic disorders.
Gökhan S Hotamisligil. Nature 2006
10

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.
Arun J Sanyal, Naga Chalasani, Kris V Kowdley, Arthur McCullough, Anna Mae Diehl, Nathan M Bass, Brent A Neuschwander-Tetri, Joel E Lavine, James Tonascia, Aynur Unalp,[...]. N Engl J Med 2010
10

Interferon regulatory factor 9 is a key mediator of hepatic ischemia/reperfusion injury.
Pi-Xiao Wang, Ran Zhang, Ling Huang, Li-Hua Zhu, Ding-Sheng Jiang, Hou-Zao Chen, Yan Zhang, Song Tian, Xiao-Fei Zhang, Xiao-Dong Zhang,[...]. J Hepatol 2015
58
17

Human fatty liver disease: old questions and new insights.
Jonathan C Cohen, Jay D Horton, Helen H Hobbs. Science 2011
10

Hepatocyte DUSP14 maintains metabolic homeostasis and suppresses inflammation in the liver.
Siyuan Wang, Zhen-Zhen Yan, Xia Yang, Shimin An, Kuo Zhang, Yu Qi, Jilin Zheng, Yan-Xiao Ji, Pi-Xiao Wang, Chun Fang,[...]. Hepatology 2018
34
29

Mechanisms of NAFLD development and therapeutic strategies.
Scott L Friedman, Brent A Neuschwander-Tetri, Mary Rinella, Arun J Sanyal. Nat Med 2018
10

Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.
Jorge Henao-Mejia, Eran Elinav, Chengcheng Jin, Liming Hao, Wajahat Z Mehal, Till Strowig, Christoph A Thaiss, Andrew L Kau, Stephanie C Eisenbarth, Michael J Jurczak,[...]. Nature 2012
9

Hepatocyte TRAF3 promotes insulin resistance and type 2 diabetes in mice with obesity.
Zheng Chen, Mark J Canet, Liang Sheng, Lin Jiang, Yi Xiong, Lei Yin, Liangyou Rui. Mol Metab 2015
23
39

Hepatic Oncostatin M Receptor β Regulates Obesity-Induced Steatosis and Insulin Resistance.
Pengcheng Luo, Pi-Xiao Wang, Zuo-Zhi Li, Xiao-Jing Zhang, Xi Jiang, Jun Gong, Juan-Juan Qin, Junhong Guo, Xueyong Zhu, Sijun Yang,[...]. Am J Pathol 2016
26
34

NAFLD: a multisystem disease.
Christopher D Byrne, Giovanni Targher. J Hepatol 2015
9

Interferon regulatory factors: at the crossroads of immunity, metabolism, and disease.
Guang-Nian Zhao, Ding-Sheng Jiang, Hongliang Li. Biochim Biophys Acta 2015
132
9

Time to step-up the fight against NAFLD.
Xiao-Jing Zhang, Zhi-Gang She, Hongliang Li. Hepatology 2018
24
37

Role of Innate Immune Signaling in Non-Alcoholic Fatty Liver Disease.
Jingjing Cai, Xiao-Jing Zhang, Hongliang Li. Trends Endocrinol Metab 2018
45
20

Innate Immune Signaling in Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases.
Jingjing Cai, Meng Xu, Xiaojing Zhang, Hongliang Li. Annu Rev Pathol 2019
44
20

IRF8 suppresses pathological cardiac remodelling by inhibiting calcineurin signalling.
Ding-Sheng Jiang, Xiang Wei, Xiao-Fei Zhang, Yu Liu, Yan Zhang, Ke Chen, Lu Gao, Heng Zhou, Xue-Hai Zhu, Peter P Liu,[...]. Nat Commun 2014
112
8

A central role for JNK in obesity and insulin resistance.
Jiro Hirosumi, Gürol Tuncman, Lufen Chang, Cem Z Görgün, K Teoman Uysal, Kazuhisa Maeda, Michael Karin, Gökhan S Hotamisligil. Nature 2002
8

TAK1 is a ubiquitin-dependent kinase of MKK and IKK.
C Wang, L Deng, M Hong, G R Akkaraju, J Inoue , Z J Chen. Nature 2001
8

Mindin/Spondin 2 inhibits hepatic steatosis, insulin resistance, and obesity via interaction with peroxisome proliferator-activated receptor α in mice.
Li-Hua Zhu, Aibing Wang, Pengcheng Luo, Xinan Wang, Ding-Sheng Jiang, Wei Deng, Xiaofei Zhang, Tao Wang, Yi Liu, Lu Gao,[...]. J Hepatol 2014
41
19


TAK1 regulates hepatic lipid homeostasis through SREBP.
S Morioka, K Sai, E Omori, Y Ikeda, K Matsumoto, J Ninomiya-Tsuji. Oncogene 2016
21
38



Tumor necrosis factor receptor-associated factor 3 is a positive regulator of pathological cardiac hypertrophy.
Xi Jiang, Ke-Qiong Deng, Yuxuan Luo, Ding-Sheng Jiang, Lu Gao, Xiao-Fei Zhang, Peng Zhang, Guang-Nian Zhao, Xueyong Zhu, Hongliang Li. Hypertension 2015
47
17

Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis.
Sayaka Inokuchi, Tomonori Aoyama, Kouichi Miura, Christoph H Osterreicher, Yuzo Kodama, Katsumi Miyai, Shizuo Akira, David A Brenner, Ekihiro Seki. Proc Natl Acad Sci U S A 2010
219
8

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB.
Dongsheng Cai, Minsheng Yuan, Daniel F Frantz, Peter A Melendez, Lone Hansen, Jongsoon Lee, Steven E Shoelson. Nat Med 2005
8

Reprogramming Interferon Regulatory Factor Signaling in Cardiometabolic Diseases.
Yaxing Zhang, Hongliang Li. Physiology (Bethesda) 2017
22
36

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.
Zobair Younossi, Quentin M Anstee, Milena Marietti, Timothy Hardy, Linda Henry, Mohammed Eslam, Jacob George, Elisabetta Bugianesi. Nat Rev Gastroenterol Hepatol 2018
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.